Currently, there are 119.95M common shares owned by the public and among those 106.24M shares have been available to trade.
The company’s stock has a 5-day price change of 8.43% and 22.81% over the past three months. PRVA shares are trading 13.76% year to date (YTD), with the 12-month market performance up to 6.31% higher. It has a 12-month low price of $15.92 and touched a high of $23.24 over the same period. PRVA has an average intraday trading volume of 695.92K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 8.92%, 5.65%, and 17.14% respectively.
Institutional ownership of Privia Health Group Inc (NASDAQ: PRVA) shares accounts for 98.03% of the company’s 119.95M shares outstanding.
It has a market capitalization of $2.67B and a beta (3y monthly) value of 0.85. The stock’s trailing 12-month PE ratio is 217.19, while the earnings-per-share (ttm) stands at $0.10. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.95% over the week and 3.99% over the month.
Earnings per share for the fiscal year are expected to decrease by -31.26%, and 96.50% over the next financial year.
Looking at the support for the PRVA, a number of firms have released research notes about the stock. Needham stated their Buy rating for the stock in a research note on January 10, 2025, with the firm’s price target at $25. KeyBanc Capital Markets was of a view on October 11, 2024 that the stock is Overweight, while Robert W. Baird gave the stock Outperform rating on May 30, 2024, issuing a price target of $23. Citigroup on their part issued Buy rating on April 22, 2024.
